4.8 Article

Integration of Protein Nanocage with CpG Motifs: A Virus-Mimicked Core-Shell Nanostructure to Ignite Antitumor Immunity

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways

Lukas Kraehenbuehl et al.

Summary: The discovery and clinical implementation of immune-checkpoint inhibitors like CTLA4, PD-1, and PD-L1 have significantly improved outcomes for patients with advanced-stage cancers. However, a majority of patients do not respond to these agents, emphasizing the need for further research into alternative immunomodulatory pathways and targeting tumor metabolism to enhance treatment efficacy.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

Review Biotechnology & Applied Microbiology

Identification of neoantigens for individualized therapeutic cancer vaccines

Franziska Lang et al.

Summary: This Review discusses the use of tumor-specific neoantigens in anticancer vaccines and introduces the mechanisms of neoantigen T cell recognition, as well as computational approaches to predict which neoantigens might confer proficient antitumor immunity in patients. Individualized treatment approaches are required to harness the full potential of the unique cancer mutations in each patient. Computational algorithms and machine-learning tools can be used to identify mutations, prioritize T cell-recognized antigens, and design personalized vaccines for each patient.

NATURE REVIEWS DRUG DISCOVERY (2022)

Article Multidisciplinary Sciences

Catalytical nano-immunocomplexes for remote-controlled sono-metabolic checkpoint trimodal cancer therapy

Chi Zhang et al.

Summary: The authors have developed a pH-responsive and sono-irradiation activatable nanosystem for sono-metabolic cancer immunotherapy, functionalized with anti-PD-L1 and adenosine deaminase. This system can efficiently activate immune effector cells and inhibit immune suppressor cells.

NATURE COMMUNICATIONS (2022)

Review Chemistry, Multidisciplinary

Rational Design of T-Cell- and B-Cell-Based Therapeutic Cancer Vaccines

Wen-Hao Li et al.

Summary: Cancer vaccines aim to enhance tumor-specific immune responses by engaging both T-cell and B-cell immunity. Different factors, including antigen selection, immune activation, vaccine delivery, and repeatable vaccination, should be considered for the rational design of therapeutic cancer vaccines. Chemical strategies such as adjuvants and nanomaterials play crucial roles in advancing the development of effective T-cell- and B-cell-based cancer vaccines.

ACCOUNTS OF CHEMICAL RESEARCH (2022)

Article Chemistry, Multidisciplinary

Constructing a nanocage-based universal carrier for delivering TLR- activating nucleic acids to enhance antitumor immunotherapy

Baoli Zhang et al.

Summary: In this study, a rationally designed nanocage-like protein carrier was developed for the effective delivery of TLR-activating nucleic acids. The carrier exhibited significantly improved delivery efficiency, achieving efficient cell uptake, specific lysosomal localization, and enhanced immune activation.

NANO TODAY (2022)

Review Materials Science, Multidisciplinary

Precision design of engineered nanomaterials to guide immune systems for disease treatment

Jiulong Li et al.

Summary: This review systematically investigates the molecular mechanisms of immune responses induced by engineered nanomaterials (ENMs) and emphasizes the critical role of material properties in immune modulation. It also proposes the utilization of nanotechnology to develop safe and effective immunomodulation strategies, as well as discusses the challenges and opportunities for clinical translation.

MATTER (2022)

Review Biochemistry & Molecular Biology

Engineering strategies to enhance oncolytic viruses in cancer immunotherapy

Yaomei Tian et al.

Summary: Oncolytic viruses (OVs) are a potentially useful treatment method for tumors, as they can selectively kill tumor cells without harming healthy cells and enhance antitumor immunity through inducing innate and adaptive immune responses. Genetic engineering of OVs to express immune regulators, as well as their combination with other immunotherapies, has shown promising progress in cancer treatment.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Review Biochemistry & Molecular Biology

mRNA vaccine: a potential therapeutic strategy

Yang Wang et al.

Summary: mRNA vaccines have great potential in fighting cancer and viral diseases, with advancements in sequence optimization and delivery strategies to enhance efficacy and stability, and importance in increasing antigen reactivity.

MOLECULAR CANCER (2021)

Review Oncology

Immunogenicity of CAR T cells in cancer therapy

Dimitrios L. Wagner et al.

Summary: CAR T cells have shown significant clinical responses in patients with certain advanced-stage B cell malignancies, but some patients may experience anti-CAR immune responses leading to treatment failure. Strategies to monitor and reduce the risks of anti-CAR immune responses are needed to improve CAR T cell therapy outcomes.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Editorial Material Oncology

Advancing oncolytic virus therapy by understanding the biology

Howard L. Kaufman et al.

Summary: The study confirmed previous results of oncolytic virus treatment in melanoma and revealed new mechanisms in B cell lymphoma, indicating potential for expanding the role of oncolytic viruses in cancer therapy.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Review Biochemistry & Molecular Biology

Pattern recognition receptors in health and diseases

Danyang Li et al.

Summary: Pattern recognition receptors (PRRs) are a class of receptors that can directly recognize specific molecular structures on pathogens, apoptotic host cells, and damaged senescent cells, bridging nonspecific immunity and specific immunity. Through the recognition and binding of ligands, PRRs can produce immunoprotective effects against infections and tumors. Research on PRRs and their ligands has greatly enhanced understanding of the signaling pathways involved, providing insights for the treatment of immune-related diseases and tumors.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Oncology

Systemic immunity in cancer

Kamir J. Hiam-Galvez et al.

Summary: Understanding systemic immune landscape beyond the tumour microenvironment is crucial in assessing the effectiveness of immunotherapy in cancer treatment. Despite the potential of immunotherapy to induce new immune responses, compromised immune responses in individuals with tumors may limit its efficacy.

NATURE REVIEWS CANCER (2021)

Article Chemistry, Multidisciplinary

Biomimetic Nanotechnology toward Personalized Vaccines

Jiarong Zhou et al.

ADVANCED MATERIALS (2020)

Article Cell Biology

Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies

Candice R. Gurbatri et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Review Biochemistry & Molecular Biology

Toll-like Receptors and the Control of Immunity

Katherine A. Fitzgerald et al.

Article Chemistry, Multidisciplinary

Bioengineered Nanocage from HBc Protein for Combination Cancer Immunotherapy

Wenjun Shan et al.

NANO LETTERS (2019)

Review Multidisciplinary Sciences

cGAS in action: Expanding roles in immunity and inflammation

Andrea Ablasser et al.

SCIENCE (2019)

Article Immunology

Nonclassical Monocytes in Health and Disease

Prakash Babu Narasimhan et al.

Annual Review of Immunology (2019)

Review Oncology

Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy

Anping Li et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

Review Cell Biology

Macrophages and Metabolism in the Tumor Microenvironment

Ilio Vitale et al.

CELL METABOLISM (2019)

Review Biotechnology & Applied Microbiology

Optimizing oncolytic virotherapy in cancer treatment

Kevin Harrington et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Review Immunology

Cold Tumors: A Therapeutic Challenge for Immunotherapy

Paola Bonaventura et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Cell Biology

Mechanisms of clathrin-mediated endocytosis

Marko Kaksonen et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)

Review Biochemistry & Molecular Biology

Detection of Microbial Infections Through Innate Immune Sensing of Nucleic Acids

Xiaojun Tan et al.

ANNUAL REVIEW OF MICROBIOLOGY, VOL 72 (2018)

Review Immunology

Integrating oncolytic viruses in combination cancer immunotherapy

Praveen K. Bommareddy et al.

NATURE REVIEWS IMMUNOLOGY (2018)

Review Immunology

Immunogenic cell death in cancer and infectious disease

Lorenzo Galluzzi et al.

NATURE REVIEWS IMMUNOLOGY (2017)

Article Nanoscience & Nanotechnology

In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer

P. H. Lizotte et al.

NATURE NANOTECHNOLOGY (2016)

Review Oncology

Rationale for anti-OX40 cancer immunotherapy

Sandrine Aspeslagh et al.

EUROPEAN JOURNAL OF CANCER (2016)

Review Immunology

T Cell Antigen Receptor Recognition of Antigen-Presenting Molecules

Jamie Rossjohn et al.

ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)

Article Oncology

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

Robert H. I. Andtbacka et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Review Chemistry, Multidisciplinary

Endocytosis at the nanoscale

Irene Canton et al.

CHEMICAL SOCIETY REVIEWS (2012)

Review Oncology

The blockade of immune checkpoints in cancer immunotherapy

Drew M. Pardoll

NATURE REVIEWS CANCER (2012)

Review Multidisciplinary Sciences

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion

Robert D. Schreiber et al.

SCIENCE (2011)

Review Cell Biology

CD44: From adhesion molecules to signalling regulators

H Ponta et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)

Article Critical Care Medicine

Costimulation of T cells

L Bugeon et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)